Literature DB >> 23248664

Multiple intracranial hemorrhages in a normotensive demented patient: A probable cerebral amyloid angiopathy.

Ahmad Chitsaz1, Rasul Norouzi, Seyed Mohammad Javad Marashi, Marzieh Salimianfard, Salman Abbasi Fard.   

Abstract

Cerebral amyloid angiopathy (CAA) is the most common cause of lobar intracerebral hemorrhage. Repeated bleeding may be presented with vascular dementia. We have reported a 68-year-old normotensive demented patient with probable CAA presented with hemiparesia, headache and vomiting. According to the experience of this case, it is recommended to consider CAA for normotensive elderly patients presented with multiple and superficial intracerebral hemorrhage.

Entities:  

Keywords:  Cerebral Amyloid Angiopathy; Dementia; Intra Cerebral Hemorrhage

Year:  2012        PMID: 23248664      PMCID: PMC3523427     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


Cerebral amyloid angiopathy (CAA) is the condition of amyloid deposition in the wall of cerebral cortex and lep-tomeninges vessels making them weak and more fragile.12 The condition is more often asymptomatic.3 However, it can present as several clinicopathologic entities. The most common presentations are intracerebral he-morrhage (ICH) and dementia.4 Definite diagnose is depended on brain tissue sampling and this usually made after death or when a biopsy of the blood vessels of the brain during the surgery is done.5 Tissue sampling is not available for all suspicious patients; therefore, we should consider probable diagnosis based on Boston criteria.6 Here, we report a case of probable CAA that referred to Alzahra Hospital, Isfahan, Iran, in 2011.

Case report

A normotensive 68-year-old male who suffered from dementia without parkinsonism sign and symptoms, presented with hemiparesia without any decrease in level of consciousness. Symptoms started since two weeks before admission with headache, nausea, vomiting and hemiparesia. The severity of headache and permanent weakness forced the patient and his relatives seeking medical care. Past medical history revealed a progressive dementia since one year ago without history of hypertension or other related medical conditions. He did not have any history of trauma, but he had two attacks of transient hemiparesia and headache in previous year neglected as senile symptoms. Other than hemiparesia, neurological examination at the first day and at the time of discharge revealed that cognition impairment was compatible with subcortical dementia. Laboratory examinations, including: complete blood counts, electrolytes, liver and renal function tests, and coagulation tests were all within normal ranges. Computed tomography (CT) showed three well defined hyperdense cortical lesions over the both parietal lobes and left insular lobe without mass effect or surrounding edema (Figure 1). The further investigation using magnetic resonance imaging (MRI) with administration of contrast agent revealed neither further enhancements nor additional information compared to CT scan (Figure 2).
Figure 1

Spiral brain CT scan on admission

Figure 2

Brain MRI with and without contrast agent on third day

Spiral brain CT scan on admission Brain MRI with and without contrast agent on third day After 2 weeks, while the patient was hospitalized, we took another CT scan, and there was no evidence of previous lesions as shown in figure 3. Therefore, according to a documented multiple superficial intracerebral hemorrhage and other criteria, diagnose of probable CAA was introduced. Throughout the hospitalization, standard management of ICH was done7 and finaly, the patient was discharged with the order of cognitive enhancer drugs and rehabilitation.
Figure 3

Spiral brain CT scan two weeks later

Spiral brain CT scan two weeks later

Discussion

Dementia and ICH are the main clinical presentations of CAA.8 CAA is the most frequent cause of lobar ICH in the elderly.9 The condition is typically observed in normotensive adults over 60 years old.1310 In contrast to deep distributed ICH resulting from hypertension, the location in CAA is generally superficial.1011 CAA is more often asymptomatic3 and in the brain autopsy of more than 40% of normotensive persons over the age of 70, we can find amyloid changes.12 Dementia may be seen earlier than symptomatic ICH in 25 to 40% of patients and can be slowly progressive, similar to that seen in Alzheimer disease.3 The most common type of CAA is sporadic and associated with increasing age. Sporadic CAA can involve multiple lobes.9 Angiography and MRI are conventionally used for assessment, but the angiography is not useful.13 Multiple regions of the signal void in gradient echo MRI implys multiple distributed petechial hemorrhages and make the diagnosis of CAA.3 For the standard diagnosis of CAA, Boston's criteria36 were made in 1990: --Definite CAA: Full postmortem examination indicative of CAA + lack of other diagnostic lesions --Probable CAA with supporting pathology: Clinical data and histopathological sample (evacuated hematoma or biopsy) indicative of some degree of CAA in the sample + lack of other diagnostic lesions. --Probable CAA: Clinical data and MRI or CT indicative of multiple hemorrhages limited to lobar, cortical, or corticosubcortical areas (cerebellar hemorrhage allowed) in subjects aged > 55 years. --Possible CAA: Clinical data and MRI or CT indicative of single lobar, cortical, or corticosub-cortical area hemorrhage in subjects aged > 55. At present, there is no confirmed treatment to stop the progression of CAA,9 but prevention from further hemorrhage and symptomatic treatment of seizures and related symptoms are recommended.1 CAA usually has poor prognoses. Each experience of hemorrhage brings the increasing risk of disability and dependence with permanent brain damage or even death.4 The management of ICH related to CAA is the same to the standard management of ICH with particular attention for usage of anticoagulant, management of intracranial pressure, and preventing complications. When the ICH causes a prominent mass effect and patient is impending to herniation, a prompt evacuation of hematoma can be life saving.4 Recurrence of ICH in CAA is common.13 A history of hemorrhagic stroke before the index lobar hemorrhage can predict early recurrence of ICH.4 Occasionally, some medications such as those used to treatment of Alzheimer's disease may improve cognition and memory impairment. Seizures, occasionally termed “amyloid spells,” can be treated with anticonvulsants such as phenytoin and carbamazepine.5

Conclusion

In summary, as the cerebral amyloid angiopathy is the most common cause of lobar parenchymal hemorrhage in elderly, we should be cautious and consider CAA in normotensive patients presented with multiple or superficial intracerebral hemorrhage, particularly when the patient is demented with a history of hemorrhagic stroke.

Authors’ Contributions

ACh designed the study and also provided assistance in final editing of the article. RN gathered information about the patient and wrote the article. SMJM have reported the MRI and CT scan findings. MS reviewed related articles and gathered necessary information. SAF provided assistance in final editing of the article. All authors have read and approved the content of the manuscript.
  7 in total

1.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

Review 2.  Cerebral amyloid angiopathy: CT and MR imaging findings.

Authors:  Christine P Chao; Amy L Kotsenas; Daniel F Broderick
Journal:  Radiographics       Date:  2006 Sep-Oct       Impact factor: 5.333

Review 3.  Cerebral amyloid angiopathy. A critical review.

Authors:  H V Vinters
Journal:  Stroke       Date:  1987 Mar-Apr       Impact factor: 7.914

Review 4.  Cerebral amyloid angiopathy and dementia.

Authors:  J Tian; J Shi; D M A Mann
Journal:  Panminerva Med       Date:  2004-12       Impact factor: 5.197

Review 5.  Sporadic and familial cerebral amyloid angiopathies.

Authors:  Tamas Revesz; Janice L Holton; Tammaryn Lashley; Gordon Plant; Agueda Rostagno; Jorge Ghiso; Blas Frangione
Journal:  Brain Pathol       Date:  2002-07       Impact factor: 6.508

6.  Amyloid angiopathy and lobar cerebral haemorrhage.

Authors:  N Ishii; Y Nishihara; A Horie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

7.  Dementia in cerebral amyloid angiopathy: a clinicopathological study.

Authors:  M Yoshimura; H Yamanouchi; S Kuzuhara; H Mori; S Sugiura; T Mizutani; H Shimada; M Tomonaga; Y Toyokura
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.